OPC-51803

CAS No. 192514-54-8

OPC-51803( —— )

Catalog No. M34361 CAS No. 192514-54-8

OPC-51803 is an orally available nonapeptidylpressor (AVP) V(2) receptor selective agonist for the treatment of urinary incontinence and nocturia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 532 Get Quote
5MG 787 Get Quote
10MG 1074 Get Quote
25MG 1463 Get Quote
50MG 1822 Get Quote
100MG 2250 Get Quote
500MG 4410 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    OPC-51803
  • Note
    Research use only, not for human use.
  • Brief Description
    OPC-51803 is an orally available nonapeptidylpressor (AVP) V(2) receptor selective agonist for the treatment of urinary incontinence and nocturia.
  • Description
    OPC-51803 is an orally available nonapeptidylpressor (AVP) V(2) receptor selective agonist for the treatment of urinary incontinence and nocturia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Vasopressin Receptor
  • Recptor
    Vasopressin Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    192514-54-8
  • Formula Weight
    454
  • Molecular Formula
    C26H32ClN3O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(=O)(N1C=2C([C@@H](CC(NC(C)C)=O)CCC1)=CC=CC2)C3=C(Cl)C=C(C=C3)N4CCCC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • OPC-51803

    OPC-51803 is an orally available nonapeptidylpressor (AVP) V(2) receptor selective agonist for the treatment of urinary incontinence and nocturia.

  • Balovaptan

    Balovaptan is a highly potent and selective brain-penetrant vasopressin 1a (hV1a) receptor antagonist.

  • Desmopressin acetate

    Desmopressin is the synthetic analog of the antidiuretic hormone arginine vasopressin. Vasopressin Receptor The antidiuretic properties of desmopressin have led to its use in polyuric conditions including primary nocturnal enuresis nocturia and diabetes insipidus.